In 2023, Japan's government expenditure on R&D in health was approximately 1.70 billion USD PPP. From 2024 to 2028, projections indicate a steady growth trajectory, starting at 1.74 billion USD PPP in 2024 and reaching 1.92 billion USD PPP by 2028. This represents a compound annual growth rate (CAGR) of about 2.5%. The consistent year-on-year increase shows Japan's commitment to enhancing its investment in health R&D.
Future trends to watch for include:
- Potential policy shifts that could impact budget allocations.
- Global health challenges influencing increased R&D spending.
- Technological advancements driving more focused R&D expenditures.
